Severe acute hepatitis following intravenous amiodarone : a case report and review of the literature.

Abstract

There is sufficient evidence to support amiodarone induced acute hepatotoxicity as a unique entity separate from ischemic hepatitis. If suspected, parenteral amiodarone should be discontinued and held indefinitely.